U.S. flag

An official website of the United States government

NM_052845.4(MMAB):c.116G>A (p.Gly39Asp) AND Methylmalonic aciduria, cblB type

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Apr 10, 2020
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001277395.1

Allele description [Variation Report for NM_052845.4(MMAB):c.116G>A (p.Gly39Asp)]

NM_052845.4(MMAB):c.116G>A (p.Gly39Asp)

Genes:
MMAB:metabolism of cobalamin associated B [Gene - OMIM - HGNC]
MVK:mevalonate kinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
12q24.11
Genomic location:
Preferred name:
NM_052845.4(MMAB):c.116G>A (p.Gly39Asp)
HGVS:
  • NC_000012.12:g.109573365C>T
  • NG_007096.1:g.5133G>A
  • NG_007702.1:g.4671C>T
  • NM_052845.4:c.116G>AMANE SELECT
  • NP_443077.1:p.Gly39Asp
  • LRG_156:g.4671C>T
  • NC_000012.11:g.110011170C>T
  • NR_038118.2:n.140G>A
Protein change:
G39D
Links:
dbSNP: rs1466525448
NCBI 1000 Genomes Browser:
rs1466525448
Molecular consequence:
  • NM_052845.4:c.116G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NR_038118.2:n.140G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Methylmalonic aciduria, cblB type (MACB)
Synonyms:
METHYLMALONIC ACIDURIA, VITAMIN B12-RESPONSIVE, DUE TO DEFECT IN SYNTHESIS OF ADENOSYLCOBALAMIN, cblB TYPE; Methylmalonic acidemia cblB type; Vitamin B12-responsive methylmalonic acidemia type cblB
Identifiers:
MONDO: MONDO:0009614; MedGen: C1855102; Orphanet: 28; Orphanet: 79311; OMIM: 251110

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001464343Natera, Inc.
no assertion criteria provided
Uncertain significance
(Apr 10, 2020)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Natera, Inc., SCV001464343.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024